Long-acting reversible contraception and permanent contraception provision following abortion restrictions: Trends from a multisite southeastern academic medical center
Abortion and contraception
Awarded 2024
Uta Landy Complex Family Planning Scholars
Rachel Jensen, MD
University of North Carolina

I am currently a fellow in Complex Family Planning at the University of North Carolina. I attended undergraduate and medical school at Northwestern University, and subsequently completed my residency in Obstetrics and Gynecology at the University of Maryland in Baltimore. While I have engaged in research throughout my medical training, in the past several years I have discovered a true passion for research, with a particular interest in the impacts of healthcare policy on healthcare delivery and patient outcomes. As a CFP fellow practicing in the Southeast, I hope that research can help us to better understand the clinical consequences of abortion restrictions and to find innovative and evidence-based solutions for healthcare delivery in the face of these limitations. My primary fellowship research project focuses on the impact of the Dobbs decision and subsequent abortion restrictions on contraception provision. Limited access to abortion may increase interest in more effective contraceptive methods, such as long-acting reversible contraception (LARC) and permanent contraception. The goal of this project is to compare institutional trends in LARC and permanent contraception use before and after the Dobbs decision, and after the passage of Senate Bill 20 in North Carolina, which imposed a 12-week abortion ban and other restrictions on abortion in NC. Understanding these trends can prompt improvements in patient counseling and allocation of health care resources, and may influence future health policy.